San Francisco Sentry Investment Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $181K | Sell |
2,627
-302
| -10% | -$20.2K | 0.09% | 213 |
|
|
2021
Q1 | $190K | Sell |
2,929
-455
| -13% | -$29.3K | 0.08% | 231 |
|
|
2020
Q4 | $197K | Sell |
3,384
-92
| -3% | -$5.55K | 0.09% | 204 |
|
|
2020
Q3 | $219K | Buy |
3,476
+4
| +0.1% | +$277 | 0.11% | 179 |
|
|
2020
Q2 | $267K | Buy |
3,472
+2,217
| +177% | +$170K | 0.14% | 151 |
|
|
2020
Q1 | $94K | Buy |
1,255
+727
| +138% | +$50.2K | 0.06% | 229 |
|
|
2019
Q4 | $34K | Sell |
528
-11
| -2% | -$716 | 0.02% | 423 |
|
|
2019
Q3 | $34K | Sell |
539
-512
| -49% | -$33.5K | 0.02% | 420 |
|
|
2019
Q2 | $71K | Buy |
1,051
+16
| +2% | +$1.05K | 0.03% | 330 |
|
|
2019
Q1 | $67K | Sell |
1,035
-359
| -26% | -$23.9K | 0.03% | 365 |
|
|
2018
Q4 | $88K | Sell |
1,394
-63
| -4% | -$4.4K | 0.04% | 303 |
|
|
2018
Q3 | $112K | Buy |
1,457
+186
| +15% | +$14K | 0.04% | 296 |
|
|
2018
Q2 | $90K | Sell |
1,271
-3,504
| -73% | -$247K | 0.04% | 324 |
|
|
2018
Q1 | $360K | Buy |
4,775
+7
| +0.1% | +$556 | 0.1% | 184 |
|
|
2017
Q4 | $341K | Sell |
4,768
-2,525
| -35% | -$192K | 0.1% | 191 |
|
|
2017
Q3 | $591K | Buy |
7,293
+199
| +3% | +$15.2K | 0.2% | 120 |
|
|
2017
Q2 | $502K | Buy |
7,094
+593
| +9% | +$39.5K | 0.18% | 122 |
|
|
2017
Q1 | $442K | Sell |
6,501
-754
| -10% | -$53K | 0.24% | 103 |
|
|
2016
Q4 | $520K | Sell |
7,255
-2,073
| -22% | -$154K | 0.3% | 87 |
|
|
2016
Q3 | $738K | Sell |
9,328
-37
| -0.4% | -$3.01K | 0.44% | 68 |
|
|
2016
Q2 | $781K | Buy |
9,365
+203
| +2% | +$18K | 0.48% | 67 |
|
|
2016
Q1 | $841K | Buy |
9,162
+4,574
| +100% | +$412K | 0.5% | 60 |
|
|
2015
Q4 | $464K | Buy |
4,588
+1,398
| +44% | +$145K | 0.29% | 92 |
|
|
2015
Q3 | $313K | Buy |
3,190
+351
| +12% | +$39K | 0.22% | 116 |
|
|
2015
Q2 | $332K | Buy |
2,839
+151
| +6% | +$16.5K | 0.2% | 121 |
|
|
2015
Q1 | $264K | Buy |
+2,688
| New | +$273K | 0.16% | 131 |
|
|
2014
Q4 | – | Sell |
-1,361
| Closed | -$145K | – | 252 |
|
|
2014
Q3 | $145K | Buy |
1,361
+182
| +15% | +$17.8K | 0.07% | 187 |
|
|
2014
Q2 | $98K | Sell |
1,179
-120
| -9% | -$9.34K | 0.05% | 232 |
|
|
2014
Q1 | $92K | Buy |
1,299
+236
| +22% | +$18.5K | 0.03% | 282 |
|
|
2013
Q4 | $80K | Buy |
1,063
+125
| +13% | +$8.7K | 0.03% | 279 |
|
|
2013
Q3 | $59K | Hold |
938
| – | – | 0.02% | 290 |
|
|
2013
Q2 | $48K | Buy |
+938
| New | +$48.9K | 0.02% | 309 |
|
Other funds holding GILD
San Francisco Sentry Investment Group's GILD Position: Q2 2021 in Review
San Francisco Sentry Investment Group reduced its Gilead Sciences (GILD) stake by 10% in Q2 2021, selling an estimated $20.2K and leaving 2,627 shares worth $181K. The position accounts for 0.09% of the portfolio, ranked #213.
San Francisco Sentry Investment Group first reported a position in GILD in Q2 2013 and has held it in 32 quarters since. The position peaked at $841K in Q1 2016. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.
- San Francisco Sentry Investment Group held 2,627 shares of Gilead Sciences worth $181K as of Q2 2021.
- San Francisco Sentry Investment Group sold 302 Gilead Sciences shares in Q2 2021, an estimated $20.2K.
- Gilead Sciences made up 0.09% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #213 holding.
- San Francisco Sentry Investment Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 32 quarters since.
- San Francisco Sentry Investment Group's Gilead Sciences position peaked at $841K in Q1 2016.
- 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.
Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.